Conversely, there was significant upregulation in treated versus untreated tumor tissue of IL18R1 and significant downregulation of IL12RB2, which are both implicated in NK cell functions (27), supporting the pattern across canine immunotherapies in which both activation and inhibition are observed simultaneously. Here, IL18R1 is linked to neoplasm.